Talviraline

DB07885InvestigationalSmall molecule

Talviraline has been used in trials studying the treatment of HIV Infections.

Chemical structure of Talviraline
Formula / weight
C15H20N2O3S2 · 340.461 g/mol (avg)
Code names
HBY-097

Resolves to

Compound
UNIIXZ4KT6MO4XCAS163451-80-7ChEMBLCHEMBL430488PubChem3000493
Structure
InChIKeyGWKIPRVERALPRD-ZDUSSCGKSA-NSMILES[H][C@@]1(CSC)N(C(=O)OC(C)C)C2=C(NC1=S)C=CC(OC)=C2
Targets
P03366gag-pol

What you can answer from here — as of February 21, 2021

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Talviraline, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In